- Brand names:
- Pharmaceutical Company:
- Condition/Indication:
- Meeting Date: July 2015
- Public Summary Document (PSD) July 2015 PBAC Meeting - PDF
- Public Summary Document (PSD) July 2015 PBAC Meeting - Word
Ustekinumab – July 2015
Ustekinumab; 45 mg/0.5 mL injection vial,1; Stelara®
Last updated
13 November 2015